Medtronic
 
 

Medtronic
Vision 3D™
Portfolio

Maximo® II Family of Devices
CRT-D, DR and VR ICDs

Maximo II Family of Devices CRT-D, DR and VR ICDs

Wireless Efficiency Integrating Medtronic’s Best Pacing and ICD Exclusives

with Conexus® Wireless Telemetry

Wireless Connectivity

Safer, more efficient implants

  • Reduce implant time
  • Program devices anytime during implant
  • Decrease potential for infection

Easy remote follow-up

Wireless telemetry you can trust

  • Dedicated MICS frequency band protects against interference from cell phones and other common wireless devices
  • SmartRadio™ Technology automatically searches and selects the clearest dedicated channel

Only from Medtronic

Flexibility Means Risk Reduction

Programmable options provide noninvasive solutions for some complex cases

  • Programmable RV Sensing may resolve T-wave oversensing and other sensing issues that may lead to inappropriate shocks
  • Avoid surgical intervention and enhance safety for patients via Programmable SVC Coil

Medtronic Pain Free™ Solutions—Proven Strategies to Reduce Shocks

Shocks save lives. Reducing unnecessary shocks improves them.

  • Only Medtronic ICDs are proven to eliminate three out of four shocks, thus improving patient quality of life1
  • ATP During Charging provides patients the double protection of receiving painless ATP, yet allows no delay to shock if needed1
  • Superior Battery Technology—Ensures short, consistent charge times for the life of the device

Better Disease Management
Successful options only from Medtronic

  • MVP®—Reduces unnecessary RV pacing by 99%*2
  • Wireless—Provides advantages in safety and efficiency with Conexus® Wireless Telemetry
  • Cardiac Compass® Trends and Heart Failure Management Report—Offer 14 months of trended daily data
  • Includes four real-time EGM channels and 80% more storage of dual channel EGM
  • Offers at-a-glance diagnostics with Quick Look™ II

Maximo® II CRT-D

Maximo® II DR

Maximo® II VR
  • 7.7 seconds BOS**
  • 9.3 seconds RRT***
  • 6.0 years longevity4
  • 38 cc, 68 g
  • 7.7 seconds BOS**
  • 9.2 seconds RRT***
  • 7.6 years longevity5
  • 37 cc, 68 g
  • 7.7 seconds BOS**
  • 9.4 seconds RRT***
  • 8.8 years longevity6
  • 37 cc, 68 g

*Median number
**Beginning of Service
***Recommended Replacement Time

References
  1. Medtronic Maximo® II CRT-D and ICD System Reference Guides
  2. Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Heart Rhythm. 2005;Abstract AB21-1.
  3. Wathen MS, DeGroot PJ, Sweeny MO, et al, for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. October 26, 2004;110(17):2591-2596.
  4. DDD, 15% atrial pacing at 60 min-1 average rate, the remaining percentage atrial tracking at 70 min-1 average rate, 100% biventricular pacing, 2.5 V/0.4 (A and RV), 3 V/0.4 (LV), 600 ohms equivalent pacing loads, pre-arrhythmia EGM storage off; 2 full energy charges per year.
  5. 50% atrial and 5% ventricular pacing in MVP Mode at 60 ppm, 2.5 V, 0.4 ms, 600 ohms; pre-arrhythmia EGM storage off; 2 full energy charges per year.
  6. 15% VVI at 60 ppm, 2.5 V, 0.4 ms, 600 ohms; pre-arrhythmia EGM storage off; 2 full energy charges per year.

Part of the Medtronic Vision 3D™ Portfolio